Navigation Links
New Data Shows Ranexa(R) Increases Glucose-Stimulated Insulin Secretion
Date:3/31/2008

logical translational and biomedical research and a distinguished fellow of cardiovascular science at CV Therapeutics.

In November 2007, the Company announced that the U.S. Food and Drug Administration was reviewing potential claims to promote Ranexa for HbA1c reduction in coronary artery disease patients with diabetes.

Ranexa is currently indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other antianginal drugs, and should be used in combination with amlodipine, beta-blockers or nitrates.

About CV Therapeutics

CV Therapeutics, Inc., headquartered in Palo Alto, California, is a biopharmaceutical company primarily focused on applying molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases.

CV Therapeutics' approved product, Ranexa(R) (ranolazine extended-release tablets), is indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other antianginal drugs, and should be used in combination with amlodipine, beta-blockers or nitrates.

CV Therapeutics also has other clinical and preclinical drug development candidates and programs, including regadenoson, which is being developed for potential use as a pharmacologic stress agent in myocardial perfusion imaging studies. Regadenoson has not been determined by any regulatory authorities to be safe or effective in humans for any use.

Except for the historical information contained herein, the matters set forth in this press release, including statements as to research and development and commercialization of products, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, includi
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
2. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
3. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
6. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
7. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
8. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
9. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
10. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
11. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)...  Roche (SIX: RO, ROG; OTCQX: RHHBY) launched its ... 2014 Clinical Lab Expo today by unveiling two booths ... is partnering with customers to redefine the value of ... day that they,re looking for a partner to help ... and offices," said Jack Phillips , president and ...
(Date:7/29/2014)... DUBLIN , July 29, 2014 ... the "Global Respiratory Devices Market 2014-2018" report ... A respiratory device is a medical ... who is having difficulty in breathing and cannot achieve ... disorders such as cystic fibrosis, asthma, COPD, and ARDS ...
(Date:7/29/2014)... Medical Corporation (Apex, TWSE: 4106), a leading player in the ... is appealing the judgment of the Regional Court of ... that found the headgear of certain mask models infringe a ... against various ResMed patents in major countries. Apex further reiterates ... ResMed filed the lawsuit with the Regional ...
Breaking Medicine Technology:Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4Global Respiratory Devices Market 2014-2018 2Apex Continues Fighting Against Patents to Free Up Competition 2
... -- China Medical Technologies, Inc. (the "Company") (Nasdaq: ... ("IVD") company, today announced that its subsidiary, Beijing GP ... sixth in the Deloitte Technology Fast 50 China 2010 ... molecular diagnostic businesses of the Company. The ...
... Oct. 21 Investigators from Texas Children,s Hospital ... North America came together in Houston to analyze ... the Berlin Heart EXCOR® Pediatric Ventricular Assist Device ... more about the study, see: http://bit.ly/bfrA1J ...
Cached Medicine Technology:China Medical Technologies Announces its Subsidiary, GP Medical, Ranked Sixth in Deloitte Technology Fast 50 China 2010 Program 2Texas Children's Hospital Hosts North American Investigators on Berlin Heart Trial 2Texas Children's Hospital Hosts North American Investigators on Berlin Heart Trial 3Texas Children's Hospital Hosts North American Investigators on Berlin Heart Trial 4
(Date:7/29/2014)... Historically, Memorial Day kicks off a ... celebrated throughout that time by picnics, barbecues and beach ... mark the start of a period that will witness ... In 2012 nearly 1.000 people were killed in crashes ... to Labor Day. , The summer's warmer weather, longer ...
(Date:7/29/2014)... 29, 2014 During his 37 years in ... & Associates, has had a steady stream of college students ... students have now gone on to dental school and some ... the shadowing program helps college students find success. , For ... given them the chance to see a realistic view of ...
(Date:7/29/2014)... 2014 A team of scientists, led ... PhD, has developed a blood test for Alzheimer’s disease ... development of Alzheimer’s disease interventions, according to an article ... puzzle, and this study represents one of several pieces ... past couple of years,” Ethell said. , The study, ...
(Date:7/29/2014)... 2014 Just months after the recent ... new states, the exciting FX family does it again! ... time farmboy from Arkansas, is shocking the world with ... technologies to the masses. This time with their ... of Jamaica. This new office is scheduled to ...
(Date:7/29/2014)... News) -- Successful negotiations may depend on more than diplomacy. ... have an advantage, according to a new study. ... successful when negotiating for themselves than men with narrower faces. ... asset when negotiations require collaboration and compromise, the researchers found. ... or not. It,s not just the big things, like a ...
Breaking Medicine News(10 mins):Health News:Narconon New Life Retreat Launches New Alcohol Prevention Program 2Health News:Arthur Bruce Dental Helps College Students 2Health News:Professor Develops Blood Test for Alzheimer’s Disease Risk 2Health News:Atlanta Special FX Rapidly Expanding Just Opens First International Corporate Office in Jamaica 2Health News:Wider Face May Give You an Edge in Negotiations 2
... CITY, Oct. 5 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: CUR), ... and delivering laboratory services, announced that it signed an ... provider of diagnostic products and services, for the promotion, ... Staging Test in the United Kingdom and Ireland. Lab21 ...
... CUR , QUEBEC CITY, Oct. 5 /PRNewswire-FirstCall/ - DiagnoCure ... cancer diagnostic tests and delivering laboratory services, announced that ... Lab21, a global provider of diagnostic products and services, ... GCC Colorectal Cancer Staging Test in the United Kingdom ...
... ... Life Insurance by KF Financial, Inc. has just launched its new, ... break from typical insurance websites with its comprehensive information, up to ... for Life Insurance is nationally recognized for helping physicians, dentists and ...
... The Lupus Foundation of America ... WASHINGTON, Oct. 5 Today, The Lewin Group, a national ... the barriers that have obstructed lupus drug development resulting in ... 50 years - since the Eisenhower Administration. The ...
... Full Extent of the Prematurity Crisis Still Unknown, March of Dimes ... than one million infants die each year because they are born ... Global and Regional Toll of Preterm Birth. , The new ... worldwide were born preterm -- defined as birth at less than ...
... combination of medications and a particular light therapy is effective ... subtropical climates. In a paper presented at the 2009 ... (AAO-HNSF) Annual Meeting & OTO EXPO in San Diego, researchers ... on dysplasia and carcinomas of the head and neck. It ...
Cached Medicine News:Health News:/R E P E A T -- DiagnoCure signs distribution agreement in the UK for its colorectal cancer test/ 2Health News:/R E P E A T -- DiagnoCure signs distribution agreement in the UK for its colorectal cancer test/ 3Health News:DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 2Health News:DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 3Health News:New Website for Disability Insurance Launched by Set for Life Insurance by KF Financial 2Health News:National Report Shines Light on Lupus 50-Year Treatment Drought 2Health News:National Report Shines Light on Lupus 50-Year Treatment Drought 3Health News:Global Death Toll: One Million Premature Babies Every Year 2Health News:Global Death Toll: One Million Premature Babies Every Year 3Health News:Global Death Toll: One Million Premature Babies Every Year 4Health News:Global Death Toll: One Million Premature Babies Every Year 5
0.5mm 1X2 Teeth with 6mm Tying Platform; in Stainless Steel 125...
... necessary addition to any ... Reichert Trial Frame provides ... smooth controls for quick, ... design, high-quality materials, and ...
... CTS utilizes a small-cone design and ... a complete, shadow-free representation of the ... system that includes the topographer, PC, ... software enables quick and easy access ...
... AL500 incorporates all of the features you ... well as a color display, auto add-lock, ... design fits easily into your existing workspace, ... glare-free viewing at any angle.,Quick and accurate, ...
Medicine Products: